EpiBiologics logo

EpiBiologics Funding & Investors

EpiBiologics develops first-in-class antibody based targeted therapies against membrane and extracellular proteins that drive underlying disease biology.

epibiologics.com

Total Amount Raised: $96,050,000

EpiBiologics Funding Rounds

  • Series A

    $23,000,000

    Series A Investors

    Codon Capital
    Taiho Ventures
    Digitalis Ventures
    Mubadala Capital Ventures
    Polaris Partners
    Vivo Capital
    GV
  • Series A

    $73,050,000

    Series A Investors

    Mubadala Capital Ventures
    Polaris Partners
    Vivo Capital
    GV
Funding info provided by Diffbot.